ATC Group: N06AA10 Nortriptyline

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N06AA10 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N06 Psychoanaleptics
3 N06A Antidepressants
4 N06AA Non-selective monoamine reuptake inhibitors
5 N06AA10 Nortriptyline

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 75 mg
PAREN - Parenteral 30 mg

Active ingredients in N06AA10

Active Ingredient Description
Nortriptyline

Nortriptyline is a tricyclic antidepressant with actions and uses similar to these of amitriptyline. It is the principal active metabolite of amitriptyline.

Related product monographs

Title Information Source Document Type  
NORTRILEN Film-coated tablet Medicines Authority (MT) MPI, EU: SmPC
PAMELOR Capsule FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Australia (AU)

Brazil (BR)

Canada (CA)

Estonia (EE)

Finland (FI)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Lithuania (LT)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.